HK Stock MarketDetailed Quotes
01558 HEC CJ PHARM
- 9.190
- -0.010-0.11%
Not Open Nov 26 16:08 CST
8.09BMarket Cap4.48P/E (TTM)
9.280High9.050Low1.29MVolume9.250Open9.200Pre Close11.79MTurnover0.20%Turnover Ratio3.68P/E (Static)879.97MShares13.30052wk High0.85P/B6.01BFloat Cap7.91052wk Low--Dividend TTM653.77MShs Float26.947Historical High--Dividend LFY2.50%Amplitude3.350Historical Low9.158Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
HEC CJ PHARM Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 5,294.88%2.13B | ---- | 105.91%39.42M | ---- | -166.03%-667.18M | ---- | -55.47%1.01B | ---- | 105.84%2.27B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -757.32%-57.78M | ---- | 40.60%-6.74M | ---- | 54.59%-11.35M | ---- | 30.66%-24.99M | ---- | -146.82%-36.04M |
| Dividend (income)- adjustment | ---- | ---247K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment loss (gain) | ---- | ---4.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | --29K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | 68.05%485.39M | ---- | 1,011.60%288.84M | ---- | --25.98M | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | --75.9M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 127.95%485.39M | ---- | 719.52%212.94M | ---- | --25.98M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -82.82%57.86M | ---- | 6,736.52%336.87M | ---- | 98.67%-5.08M | ---- | -333.28%-382.36M | ---- | ---88.25M |
| -Derivative financial instruments fair value (increase) | ---- | -90.72%79.8M | ---- | 5,969.97%859.57M | ---- | 103.70%14.16M | ---- | -333.28%-382.36M | ---- | ---88.25M |
| -Other fair value changes | ---- | 95.80%-21.93M | ---- | -2,617.15%-522.7M | ---- | ---19.24M | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | -35.85%526K | ---- | -95.70%820K | ---- | 261.97%19.07M | ---- | 9.20%5.27M | ---- | 117.93%4.83M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -35.85%526K | ---- | -95.70%820K | ---- | 261.97%19.07M | ---- | 9.20%5.27M | ---- | 117.93%4.83M |
| Depreciation and amortization: | ---- | 3.69%391.27M | ---- | 45.24%377.36M | ---- | 111.70%259.82M | ---- | 42.40%122.73M | ---- | 41.08%86.19M |
| -Depreciation | ---- | 15.31%171.76M | ---- | 48.22%148.95M | ---- | 54.50%100.5M | ---- | 29.49%65.05M | ---- | 47.28%50.23M |
| -Other depreciation and amortization | ---- | -3.89%219.51M | ---- | 43.36%228.4M | ---- | 176.21%159.32M | ---- | 60.44%57.68M | ---- | 33.25%35.95M |
| Financial expense | ---- | -19.26%227.4M | ---- | 15.52%281.65M | ---- | -0.16%243.81M | ---- | 19.41%244.21M | ---- | 14,321.93%204.5M |
| Exchange Loss (gain) | ---- | -85.76%34.42M | ---- | 588.39%241.73M | ---- | 67.08%-49.5M | ---- | -270.35%-150.36M | ---- | 930.88%88.26M |
| Special items | ---- | --45.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -79.60%6.84M |
| Operating profit before the change of operating capital | ---- | 111.94%3.31B | ---- | 945.86%1.56B | ---- | -122.36%-184.42M | ---- | -67.46%824.93M | ---- | 115.71%2.54B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -166.12%-94.02M | ---- | -135.84%-35.33M | ---- | 153.01%98.57M | ---- | -563.27%-185.95M | ---- | 63.27%-28.04M |
| Accounts receivable (increase)decrease | ---- | -167.23%-1.42B | ---- | -145.54%-530.59M | ---- | -114.96%-216.1M | ---- | 188.77%1.44B | ---- | -470.68%-1.63B |
| Accounts payable increase (decrease) | ---- | -88.61%109.49M | ---- | 353.52%961.31M | ---- | 20.97%-379.18M | ---- | -138.23%-479.79M | ---- | 1,015.42%1.25B |
| Cash from business operations | -80.32%265.04M | -2.64%1.9B | 230.34%1.35B | 387.07%1.96B | 189.02%407.69M | -142.48%-681.13M | -128.02%-457.97M | -24.93%1.6B | 29.83%1.63B | 130.50%2.14B |
| China income tax paid | -136.02%-240.64M | 9.76%-230.49M | 60.06%-101.96M | -1,471.94%-255.43M | -6,570.13%-255.27M | 106.13%18.62M | 98.70%-3.83M | 10.97%-303.73M | -46.69%-295.48M | -61.61%-341.15M |
| Net cash from operations | -98.04%24.41M | -1.57%1.67B | 716.65%1.24B | 356.59%1.7B | 133.01%152.43M | -150.98%-662.51M | -134.49%-461.8M | -27.58%1.3B | 26.62%1.34B | 150.83%1.79B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 37.87%42.83M | 801.51%60.75M | 878.64%31.06M | -40.60%6.74M | -60.89%3.17M | -54.59%11.35M | -41.90%8.12M | -30.66%24.99M | 100.62%13.97M | 146.82%36.04M |
| Dividend received - investment | ---- | --247K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Restricted cash (increase) decrease | 150.82%593.87M | -9,898.95%-1.49B | -2,057.98%-1.17B | -88.23%15.21M | -162.26%-54.15M | 158.41%129.2M | --86.98M | ---221.19M | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Sale of fixed assets | --6.32M | ---- | ---- | 2,790.91%954K | 4,857.89%942K | -99.83%33K | -99.90%19K | 332.42%19.62M | --19.76M | --4.54M |
| Purchase of fixed assets | -86.42%-401.89M | 39.71%-343.72M | 25.57%-215.59M | -60.00%-570.07M | -10.86%-289.65M | 64.16%-356.29M | 32.28%-261.26M | -72.51%-994.16M | -50.28%-385.78M | 7.06%-576.28M |
| Purchase of intangible assets | ---- | 80.07%-41.42M | 99.70%-301K | -79.77%-207.88M | -6.20%-100.17M | 85.06%-115.64M | ---94.32M | 18.96%-774.2M | ---- | -100.66%-955.32M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---78.16M |
| Recovery of cash from investments | -25.58%1.94B | --3.91B | --2.61B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | -5,580.38%-2.03B | -357.86%-1.33B | ---35.75M | ---290M | ---- | ---- | ---- | ---- | 49.66%-612.95M | ---- |
| Other items in the investment business | ---- | -179.47%-209.94M | ---- | 30.29%-75.12M | 46.23%-37.08M | 28.01%-107.76M | ---68.96M | -5.93%-149.68M | ---- | ---141.31M |
| Net cash from investment operations | -87.64%150.55M | 149.51%554.57M | 355.34%1.22B | -155.10%-1.12B | -44.77%-476.93M | 79.04%-439.11M | 65.86%-329.43M | -22.46%-2.09B | 36.61%-965M | -134.79%-1.71B |
| Net cash before financing | -92.90%174.96M | 284.27%2.23B | 858.89%2.46B | 152.63%579.75M | 58.99%-324.5M | -38.54%-1.1B | -311.56%-791.23M | -1,047.45%-795.14M | 180.46%373.99M | 738.79%83.92M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -36.80%1.06B | 317.82%2.16B | 545.60%1.68B | 16.40%517.94M | -5.66%260.77M | -14.10%444.96M | -33.31%276.4M | -27.37%518.01M | 36.85%414.43M | 1,543.36%713.2M |
| Refund | -5,550.09%-1.25B | -57.71%-255.93M | 80.71%-22.2M | -2.92%-162.28M | 25.08%-115.08M | -12,514.24%-157.68M | ---153.6M | 99.57%-1.25M | ---- | -2,800.00%-290M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.7B |
| Interest paid - financing | 34.75%-51.16M | -22.69%-138.32M | 15.71%-78.41M | -12.97%-112.74M | ---93.02M | ---99.8M | ---- | ---- | -39,286.64%-85.47M | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.45%-219.99M | ---- | -127.56%-720.03M |
| Issuance expenses and redemption of securities expenses | ---- | -213.78%-3.05B | ---1.1B | ---971.39M | ---- | ---- | ---- | 48.84%-136.92M | -7.66%-136.92M | ---267.62M |
| Other items of the financing business | -0.29%-82.74M | -239.35%-198.72M | ---82.5M | ---58.56M | ---- | ---- | ---49.19M | -151.59%-95.22M | ---- | -2,539.19%-37.85M |
| Net cash from financing operations | -182.49%-326.25M | -87.66%-1.48B | 650.94%395.49M | -519.79%-787.03M | -28.45%52.67M | 190.07%187.48M | -61.67%73.61M | -96.92%64.63M | -92.96%192.05M | 838.27%2.1B |
| Effect of rate | 104.17%1K | 96.32%-11K | 87.23%-24K | -202.75%-299K | -163.95%-188K | 107.93%291K | -70.60%294K | -353.21%-3.67M | 11.73%1M | -65.10%1.45M |
| Net Cash | -105.29%-151.29M | 462.26%750.88M | 1,151.40%2.86B | 77.33%-207.28M | 62.12%-271.84M | -25.14%-914.14M | -226.78%-717.62M | -133.45%-730.5M | -74.98%566.04M | 833.88%2.18B |
| Begining period cash | 81.30%1.67B | -18.35%923.54M | -18.35%923.54M | -44.69%1.13B | -44.69%1.13B | -26.42%2.04B | -26.42%2.04B | 368.07%2.78B | 368.07%2.78B | -33.08%593.75M |
| Cash at the end | -59.72%1.52B | 81.30%1.67B | 340.18%3.78B | -18.35%923.54M | -35.29%859.1M | -44.69%1.13B | -60.32%1.33B | -26.42%2.04B | 17.10%3.35B | 368.07%2.78B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data